Endocrine Abstracts

In recent years non-alcoholic fatty liver disease (NAFLD) has been ascribed to conditions associated with the metabolic syndrome (MS). The high probability of an unfavorable course of NAFLD combined with MS symptoms dictates the need to search for some therapeutic approaches in the treatment of patients, given the similarity of the development mechanisms of both MS and NAFLD, i.e. the insulin-resistance. One of the drugs that reduces insulin resistance is Subetto (Subetta, NPF...